ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CVM Cel Sci Corporation New

1.36
-0.04 (-2.86%)
May 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 471,177
Bid Price
Ask Price
News -
Day High 1.41

Low
1.04

52 Week Range

High
3.23

Day Low 1.25
Share Name Share Symbol Market Stock Type
Cel Sci Corporation New CVM AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -2.86% 1.36 18:35:03
Open Price Low Price High Price Close Price Previous Close
1.41 1.25 1.41 1.27 1.40
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,809 471,177 US$ 1.33 US$ 627,757 - 1.04 - 3.23
Last Trade Type Quantity Price Currency
19:00:00 2,186 US$ 1.27 USD

Cel Sci Corporation New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
67.42M 52.26M - 0 -32.37M -0.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cel Sci News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CVM Message Board. Create One! See More Posts on CVM Message Board See More Message Board Posts

Historical CVM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.651.661.251.41336,427-0.29-17.58%
1 Month1.542.391.251.45456,712-0.18-11.69%
3 Months2.172.49781.251.73346,598-0.81-37.33%
6 Months2.213.231.252.24400,529-0.85-38.46%
1 Year2.623.231.041.89564,401-1.26-48.09%
3 Years20.1427.281.046.02721,739-18.78-93.25%
5 Years5.7340.911.049.23755,864-4.37-76.27%

Cel Sci Description

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Your Recent History

Delayed Upgrade Clock